Houston Enzymes TriEnza with DPP IV Activity, Broad-Spectrum Enzyme Product for general…
Recalling firm: National Enzyme Co
Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Mar 3, 2015.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
Lot Numbers: 53379030, 53379031, 53379032, 53379034, 53379035, 53379036, 53379037, 53379038, 53379039, 53379040, 53379041, 53380079, 53380081, 53380083, 53380085, 53380086, 53380087, 53380088, 53380089, 53380090, 53380091, 53380092, 53380093, 53380094, 53380095, 53380096, 53380097, 53380098, 53380099, 53380100, 53380101, 53380102, 53380103, 53380104, 53380105, 53380106, 53380107, 53380108, 53380109, 53380110, 53380111, 53380113, 53380114, 91980002, 91980003, and 91980004
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Houston Enzymes TriEnza with DPP IV Activity, Broad-Spectrum Enzyme Product for general Digestive Support, packaged in 90-(SKU 53379) and 180-(SKU 53380) capsule bottles. The firm name on the label is Houston Nutraceuticals, Inc. (HNI), Siloam Springs, AR (2) 9212 TRIENZA Bulk Capsules (SKU 91980) packaged in varying quantities in poly bags within corrugated containers.
Original FDA recall reason
Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol
Recall details
- Recall number
- F-0734-2014
- Event ID
- 66658
- FDA status
- Terminated
- Initiated
- Oct 30, 2013
- Reported
- Dec 25, 2013
- Classified
- Dec 13, 2013
- Terminated
- Mar 3, 2015
- Quantity
- 54,887 bottles, and 327,139 bulk capsules
- Location
- Forsyth, MO, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Where it was distributed
Domestic distribution of the product is nationwide with direct accounts in 27 states in all geographical regions. Foreign distribution consists of direct accounts in the following countries: Canada, China, Malaysia, Norway, Slovakia, South Korea, Sweden, Taiwan, and the United Kingdom.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.